Adverum Biotechnologies, Inc. Uncategorized Contracts & Agreements

Amended and Restated (Filed With SEC on August 11, 2022)

Promotion Letter between Adverum Biotechnologies, Inc. and John Rakow, dated as of June 4, 2022 (Filed With SEC on August 11, 2022)

Promotion Letter between Adverum Biotechnologies, Inc. and John Rakow, dated as of July 1 (Filed With SEC on August 11, 2022)

Promotion Letter with Julie Clark, dated May 22, 2021 (Filed With SEC on August 5, 2021)

Adverum Biotechnologies, Inc. Amended and Restated 2017 Inducement Plan (Filed With SEC on August 10, 2020)

Amended and Restated Offer Letter with Leone Patterson, dated (Filed With SEC on August 10, 2020)

Promotion Letter, dated February 21, 2020, between Adverum Biotechnologies, Inc. and Angela Thedinga (Filed With SEC on May 28, 2020)

Amended and Restated Offer Letter with Leone Patterson, dated October 24, 2018 (Filed With SEC on March 6, 2019)

2017 Inducement Plan, as amended and restated (Filed With SEC on March 6, 2019)

June 5, 2018, amendment to Editas Agreement (Filed With SEC on August 8, 2018)

Offer Letter, dated May 4, 2015, by and between Avalanche Biotechnologies, Inc. and Jennifer Cheng, Ph.D (Filed With SEC on March 6, 2018)

[ADVERUM BIOTECHNOLOGIES, INC. LETTERHEAD] (Filed With SEC on June 20, 2017)

Addendum to November 19, 2015 Offer Letter- Paul Cleveland (Filed With SEC on March 9, 2017)

www.adverumbio.com (Filed With SEC on June 13, 2016)

AVALANCHE BIOTECHNOLOGIES, INC. INDUCEMENT AWARD STOCKOPTION GRANT NOTICE (Filed With SEC on May 12, 2016)

1035 OBrien Drive, Menlo Park, CA 94025 Tel ###-###-#### | Fax ###-###-#### (Filed With SEC on May 12, 2016)

AMENDMENT NO. 1 TO ACQUISITION AGREEMENT (Filed With SEC on April 7, 2016)

[Signature page immediately follows] (Filed With SEC on February 1, 2016)

AVALANCHE BIOTECHNOLOGIES, INC. INDUCEMENT AWARD STOCKOPTION GRANT NOTICE (Filed With SEC on November 20, 2015)

[Signature page immediately follows] (Filed With SEC on November 20, 2015)

[Avalanche Biotechnologies, Inc. letterhead] (Filed With SEC on August 13, 2015)

[Avalanche Biotechnologies, Inc. letterhead] (Filed With SEC on July 23, 2015)

AVALANCHE BIOTECHNOLOGIES, INC. RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT (Filed With SEC on July 18, 2014)

665 Third Street, Suite 250, San Francisco, CA 94107 Tel ###-###-#### | Fax ###-###-#### (Filed With SEC on June 30, 2014)

1035 OBrien Drive, Menlo Park, CA 9025 Tel ###-###-#### | Fax ###-###-#### (Filed With SEC on June 30, 2014)